We are live on ! Find out more
EHI

Eagle Health Investments Portfolio holdings

AUM $603M
1-Year Est. Return 111.06%
This Fund
S&P 500
This Quarter Est. Return
-11.58%
1 Year Est. Return
+111.06%
3 Year Est. Return
+240.87%
5 Year Est. Return
+290.92%
10 Year Est. Return
–
AUM
$406M
AUM Growth
-$4.59M
Cap. Flow
+$56.2M
Cap. Flow %
13.85%
Top 10 Hldgs %
62.96%
Holding
28
New
–
Increased
11
Reduced
3
Closed
–

Top Buys

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$20.3M
2
NTRA icon
Natera
NTRA
+$14.2M
3
AMWL icon
American Well
AMWL
+$6.6M
4
CANO
Cano Health, Inc.
CANO
+$6.35M
5
DXCM icon
DexCom
DXCM
+$5.34M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$9.95M
2
BPMC
Blueprint Medicines
BPMC
+$1.59M
3
HUM icon
Humana
HUM
+$305K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HUM icon
1
Humana
HUM
$46.2B
$33.9M 8.35%
77,891
-730
-0.9% -$305K
SGEN
2
DELISTED
Seagen Inc. Common Stock
SGEN
$33.2M 8.18%
230,502
+150,002
+186% +$20.3M
AZN icon
3
AstraZeneca
AZN
$251B
$29.6M 7.28%
222,833
-83,000
-27% -$9.95M
UTHR icon
4
United Therapeutics
UTHR
$22.7B
$28.6M 7.04%
159,238
+5,800
+4% +$1.1M
IQV icon
5
IQVIA
IQV
$40B
$25.9M 6.38%
111,995
+12,418
+12% +$2.94M
ARGX icon
6
argenx
ARGX
$54.2B
$22M 5.43%
69,900
+7,568
+12% +$2.2M
VRTX icon
7
Vertex Pharmaceuticals
VRTX
$132B
$21.4M 5.28%
82,144
– –
ALNY icon
8
Alnylam Pharmaceuticals
ALNY
$29B
$21.4M 5.28%
131,244
+17,542
+15% +$2.67M
DXCM icon
9
DexCom
DXCM
$33.2B
$19.9M 4.9%
155,600
+48,800
+46% +$5.34M
INSP icon
10
Inspire Medical Systems
INSP
$1.73B
$19.6M 4.82%
76,253
– –
CANO
11
DELISTED
Cano Health, Inc.
CANO
$18.8M 4.62%
29,551
+10,073
+52% +$6.35M
NTRA icon
12
Natera
NTRA
$46.4B
$18.2M 4.49%
447,494
+235,800
+111% +$14.2M
AXNX
13
DELISTED
Axonics, Inc. Common Stock
AXNX
$16.1M 3.96%
256,465
– –
AMWL icon
14
American Well
AMWL
$232M
$16M 3.95%
190,550
+78,155
+70% +$6.6M
OM icon
15
Outset Medical
OM
$94M
$14.9M 3.68%
21,933
– –
ADPT icon
16
Adaptive Biotechnologies
ADPT
$4.09B
$14.1M 3.47%
1,014,860
+264,100
+35% +$4.15M
AGIO icon
17
Agios Pharmaceuticals
AGIO
$1.94B
$12.6M 3.09%
431,413
– –
BPMC
18
DELISTED
Blueprint Medicines
BPMC
$10.9M 2.68%
170,551
-22,088
-11% -$1.59M
GH icon
19
Guardant Health
GH
$22.8B
$10.1M 2.48%
151,960
+32,600
+27% +$2.23M
CMAX
20
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$5.34M 1.32%
23,825
– –
MRTX
21
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$4.28M 1.05%
52,000
– –
FDMT icon
22
4D Molecular Therapeutics
FDMT
$572M
$2M 0.49%
132,090
– –
BEAM icon
23
Beam Therapeutics
BEAM
$2.82B
$1.66M 0.41%
28,900
– –
KYMR icon
24
Kymera Therapeutics
KYMR
$9.01B
$1.57M 0.39%
37,000
– –
ARVN icon
25
Arvinas
ARVN
$585M
$1.55M 0.38%
23,000
– –
1
2

Similar funds

PIFP
Partners in Financial Planning Salem, Virginia $603M AUM 12.72% 1-Year Est. Return
IECM
Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return
ERWM
Elk River Wealth Management Denver, Colorado $602M AUM 22.77% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $602M AUM 165.22% 1-Year Est. Return
JHCP
Jackson Hole Capital Partners Tulsa, Oklahoma $605M AUM 22.77% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
OCAM
Onex Canada Asset Management Toronto, Ontario, Canada $601M AUM 15.16% 1-Year Est. Return

Eagle Health Investments's Q1 2022 Portfolio in Review

As of Q1 2022, Eagle Health Investments held 28 positions worth $406M, down 1.1% from $410M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Eagle Health Investments deployed $56.2M of net new capital in Q1 2022, adding to 11 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was AstraZeneca, an estimated $9.95M trimmed.

  • Eagle Health Investments added most to Seagen Inc. Common Stock in Q1 2022, an estimated $20.3M increase.
  • Eagle Health Investments's biggest Q1 2022 reduction was AstraZeneca, cutting an estimated $9.95M.
  • Eagle Health Investments's ten largest holdings make up 63% of its $406M portfolio in Q1 2022.
  • Eagle Health Investments opened 0 new positions and closed 0 in Q1 2022.
  • Eagle Health Investments's portfolio value fell 1.1% quarter-over-quarter to $406M.

Based on Eagle Health Investments's 13F filing for Q1 2022, filed 12 May 2022.